Three-year outcome of rapid HIV testing at public health centers in Seoul, Republic of Korea: a short report.


Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 14 4 2020
medline: 27 4 2021
entrez: 14 4 2020
Statut: ppublish

Résumé

Before 2014, the only test used for anonymous voluntary human immunodeficiency virus (HIV) screening at public health centers (PHCs) in the Republic of Korea was an enzyme-linked immunosorbent assay (ELISA), which takes around 3 days to obtain results. In 2014, to encourage voluntary anonymous HIV screening tests, the Seoul Metropolitan Government adopted a rapid HIV screening test at PHCs. The rapid HIV screening test was introduced at four PHCs in 2014 and all 25 PHCs after 2015. We compared the numbers of HIV screening tests and confirmed positive individuals before and after introduction of the rapid HIV screening test. In 2012-2013, before the introduction of rapid HIV screening test, an average of 330 HIV screening tests were performed monthly (355 in 2012 and 305 in 2013) and 69 individuals were confirmed to have HIV in 2012 and 93 in 2013. After the introduction of the rapid HIV screening test, anonymous voluntary HIV screening increased to a monthly average of 447 tests in 2014, 2099 in 2015, and 2409 in 2016. These identified 38 new cases in 2014, 116 in 2015, and 143 in 2016. Adoption of the rapid HIV screening test has increased the number of HIV screening tests and confirmed cases.

Identifiants

pubmed: 32279532
doi: 10.1080/09540121.2020.1749550
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

525-529

Auteurs

Hye-Jin Yang (HJ)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
College of Nursing, Konyang University, Daejeon, Korea.

Jungmee Kim (J)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.

Ji Hwan Bang (JH)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
Division of Infectious Diseases, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea.

Cho Ryork Kang (CR)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
Division of Life and Health, Seoul Metropolitan Government, Seoul, Korea.

Sung-Il Cho (SI)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
Department of Epidemiology, Seoul National University Graduate School of Public Health, Seoul, Korea.

Myoung-Don Oh (MD)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Eung Soo Hwang (ES)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.

Jong-Koo Lee (JK)

Institute of Endemic Diseases, Seoul National University, Medical Research Center, Seoul, Korea.
Seoul Center for Infectious Diseases Control and Prevention, Seoul, Korea.
Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH